bicyclic peptides have emerged as a powerful tool for modulating challenging targets - Cyclingpeptides bicyclic peptides as targeting probes Bicyclic Peptides: A Promising Frontier in Therapeutic Innovation

Bicycle molecules Bicyclic peptides are rapidly emerging as a significant advancement in the field of molecular therapeutics, offering a unique combination of stability, specificity, and biological activity. These complex molecules, characterized by two distinct cyclic structures within their peptide backbone, represent a powerful tool for addressing challenging biological targets and diseases. Due to their inherent properties and versatile applications, bicyclic peptides have emerged as one of the driving forces within the constrained peptide family.作者：M Eder·2019·被引用次数：70—Here we demonstrate the power ofbicyclic peptides as targeting probes, exemplified with the tumor-overexpressed matrix metalloproteinase MT1- ...

The fundamental architecture of bicyclic peptides involves constraining short linear peptides into a stabilized bi-cyclic structureBicyclic Peptides as Next‐Generation Therapeutics - 2017. This is typically achieved through the use of a central chemical scaffold, which locks the peptide into a specific conformation. This structural constraint is key to their enhanced propertiesBiocompatible and selective generation of bicyclic peptides. Unlike their linear counterparts, bicyclic peptides are more constrained in their conformation, leading to a more defined three-dimensional shape. This rigorous control over conformation often translates to a higher affinity and exquisite selectivity for their intended biological targets.作者：M Eder·2019·被引用次数：70—Here we demonstrate the power ofbicyclic peptides as targeting probes, exemplified with the tumor-overexpressed matrix metalloproteinase MT1- ... Furthermore, the cyclization process inherently increases their resistance to degradation by proteases, a common limitation for many therapeutic proteins and peptides.作者：D Feng·被引用次数：23—Bicyclic peptides, a class of polypeptides with two loops within their structure,have emerged as powerful tools in the development of new peptide drugs. They ... Indeed, bicyclic peptides are considered to be more stable to proteases than their linear counterparts, a crucial factor for in vivo efficacy and longer half-lives作者：S Ullrich·2022·被引用次数：33—Bicyclic peptides possess superior properties for drug discovery; however, their chemical synthesis is not straightforward and often neither ....

The therapeutic potential of bicyclic peptides is vast and continues to expand.What is a Bicyclic Peptide? Research has demonstrated that they have been developed as potential therapeutics for a wide array of diseasesLight-responsive bicyclic peptides. Their ability to interact with challenging targets, such as protein-protein interactions (PPIs), makes them particularly valuableBiocompatible and Selective Generation of Bicyclic Peptides. These interactions, often characterized by large, flat surfaces that are difficult for traditional small molecules to bind effectively, can be effectively disrupted by the large binding footprint of suitably engineered bicyclic peptidesCurrent development of bicyclic peptides. This has led to their exploration in areas like oncology, where targeting aberrant protein interactions is crucial for disease control.作者：M Eder·2019·被引用次数：70—Here we demonstrate the power ofbicyclic peptides as targeting probes, exemplified with the tumor-overexpressed matrix metalloproteinase MT1- ...

Beyond direct therapeutic intervention, bicyclic peptides are also proving invaluable as drug targeting agents, imaging/diagnostic probes, and tools for biocompatible and selective generation. Their high specificity allows for precise delivery of therapeutic payloads or imaging agents directly to diseased tissues or cells, minimizing off-target effects and improving diagnostic accuracy. For example, bicyclic peptides have been explored as targeting probes for specific biomarkers, such as the tumor-overexpressed matrix metalloproteinase MT1-MMP.Five Types of Skin-Repairing Peptides - Prospector Knowledge Center This targeted approach maximizes therapeutic benefit while reducing systemic toxicity作者：C Ernst·2018·被引用次数：16—Compared to monocyclic peptides of comparable molecular mass,bicyclic peptides are more constrained in their conformation. As a result, they can bind to their ....

The development of bicyclic peptides also extends to specialized applications. Researchers are investigating light-responsive (LR) bicyclic macrocycles, which can be activated by external light stimuli. This offers a novel way to control drug release or biological activity remotely, providing an additional layer of precision in therapeutic delivery. Another area of active research involves bridged bicyclic peptides (BBPs), which incorporate additional bridging elements to further enhance structural rigidity and fine-tune binding characteristics. The synthesis of these bridged bicyclic peptides often involves double cyclization of linear peptides prepared via solid-phase peptide synthesis.

The synthesis of bicyclic peptides can be complex, but advancements in chemical and chemoenzymatic methods are making their production more accessible. Methods like synthesis of DNA-encoded bicyclic peptides via cysteine and chemoenzymatic tandem cyclization are facilitating the creation of these complex moleculesBicycle® Peptides. The ability to create these structures easily synthesized from cysteine-containing peptides with appending maleimides, for instance, opens up new avenues for library generation and drug discovery. Furthermore, the development of fully synthetic short peptides that are constrained to form two loops, stabilizing their structural geometry, as seen in Bicycle Therapeutics and their fully synthetic short peptides, represents a significant step forward.

These innovations position bicyclic peptides as next-generation pharmaceuticals2025年11月6日—Bicyclic peptides, with two cyclic substructures,have emerged as a powerful tool for modulating challenging targetssuch as protein–protein .... They combine the desirable properties of antibodies, such as high affinity and specificity, with the advantages of small molecules, including good oral bioavailability and intracellular penetration.作者：C Heinis·2009·被引用次数：932—Here we describe a phage strategy for the selection of ligands based onbicyclicor linearpeptidesattached covalently to an organic core. This hybrid nature allows them to overcome limitations of both traditional modalities. As such, bicyclic peptides form one of the most promising platforms for drug development due to their inherent biocompatibility, similarity to endogenous proteins, and remarkable chemical diversity.

In summary, bicyclic peptides represent a cutting-edge class of molecules with profound implications for medicineWho Should NOT Take Peptides? - SynergenX. Their unique structural features confer superior metabolic stabilities and target specificities compared to their linear or mono-cyclic counterparts.Bicyclic Peptides as Next-Generation Therapeutics - PubMed The ongoing research and development in this area, including the exploration of multivalent peptides and the application of cycling peptides in drug discovery, underscore their growing importanceBicyclic Peptides as Next‐Generation Therapeutics - 2017. With their good stability, high specificity, high affinity and low toxicity, bicyclic peptides are poised to revolutionize therapeutic interventions and diagnostic capabilities, offering hope for more effective and targeted treatments across a broad spectrum of diseases. The inherent potential of bicyclic peptides to modulate challenging targets and their designation as "a powerful tool for modulating challenging targets" solidify their status as a critical area of innovation in modern pharmaceutical science.